30 December
All suburbs within NWMPHN


Three per cent of Victorians live with viral hepatitis in the NWMPHN catchment. The prevalence of hepatitis B in Melbourne, Yarra, Brimbank, Darebin and Maribyrnong, and the incidence of hepatitis C in Melbourne, Brimbank, Darebin, Hobsons Bay, Maribyrnong, Melton and Wyndham, are higher than the Victorian averages.

If left untreated, both hepatitis B and hepatitis C can lead to serious liver disease, liver cancer and death.

Recent changes to the prescribing and dispensing of hepatitis B and hepatitis C treatment have improved access and availability. These changes include access to hepatitis B and hepatitis C medicines through community pharmacies and the listing of new direct-acting antivirals (DAAs) to treat hepatitis C on the Pharmaceutical Benefits Scheme (PBS) General Schedule.

These changes mean more people with hepatitis B and hepatitis C can receive treatment in primary care. There is a pressing need to train and support the primary health workforce to increase screening, treatment and management of people with and/or at risk of hepatitis B and hepatitis C.

NWMPHN has identified both hepatitis B and hepatitis C as priorities. In particular, NWMPHN is focusing on prevention, testing, treatment, and reducing stigma and discrimination, in alignment with the Victorian hepatitis B strategy 2016-2020 and Victorian hepatitis C strategy 2016-2020.


Part of NWMPHN’s hepatitis B and hepatitis C work includes commissioning organisations, with relevant expertise and experience, to deliver projects within our catchment that:

  1. Impact on workforce capacity building and/or health literacy in the hepatitis sector.
  2. Meet at least one of the following objectives:
    • Improve the skills and knowledge of the primary care workforce (including GPs, nurses, pharmacists and needle syringe program workers) about hepatitis B and hepatitis C.
    • Develop health literacy resources in English and other languages for people with or at risk of hepatitis B or hepatitis C, including Aboriginal and Torres Strait Islander people and current drug users.
    • Encourage people at risk of hepatitis B and hepatitis C to seek testing and treatment where appropriate.
    • Support the primary care workforce to screen, manage and treat people with hepatitis B or hepatitis C.
    • Reduce stigma and discrimination among people with or at risk of hepatitis B and hepatitis C.

Services involved:

  • ASHM
  • Hepatitis Victoria
  • The Pennington Institute
  • St Vincent’s Hospital

Subscribe to NWMPHN

Keep up to date with the latest news and publications, funding opportunities, careers and upcoming events at NWMPHN.

Want to collaborate with us?

Share your thoughts on how the primary health care system can be improved in North Western Melbourne.